6 -Public Involvement
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | ||
|---|---|---|
Name |
ECAPN - European Child & Adolescent Psychopharmacology Network |
|
| Involvement of patients, parents or their organisations in the protocol design | Yes | Parent and carers associations are regularly involved in designing and implementing Academic trials; they are consulted by members also for industrial trials (Autism Europe, ADHD Europe, HyperSupers – TDAH, France, AIFA.Italy, ADDIS UK, Young advisors);. Contacts have been also established with KIDS Barcelona (http://www.icanresearch.org/barcelona/; member of the iCAN network), GAMIAN and EUFAMI in order to define future formal collaborations. |
| Involvement of patients, parents or their organisations in creating the protocol info package | Yes | Parent and young people organisations are regularly involved in preparing protocol information packages for academic studies; they are also locally consulted for Industrial clinical trials ( see above). Young advisors have participated in the Milestone project. Contacts have been also established with KIDS Barcelona (http://www.icanresearch.org/barcelona/; member of the iCAN network) in order to define future formal collaborations. |
| Involvement of patients, parents or their organisations in prioritisation of needs for Clinical Trials | Yes | Parent Associations are periodically consulted in order to prioritize the needs for clinical trials in children. Contacts have been also established with KIDS Barcelona (http://www.icanresearch.org/barcelona/; member of the iCAN network) in order to define future formal collaborations. GAMIAN, EUFAMI, Kids Barcelona and different national organisations have been contacted to participate in and update about unmet needs in child and adolescent psychopharmacology. |